REF21 results recognise School's research that supports the discovery, development and optimised use of medicines and therapeutics to tackle some of the world’s most debilitating and life-threatening diseases.
Dr Meike Heurich at the School of Pharmacy has co-authored a paper with other researchers from Cardiff University and the US that may have found a trigger leading to extremely rare blood clots linked to a viral vector based COVID-19 vaccine